Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Jul;33(1):1–6. doi: 10.1128/iai.33.1.1-6.1981

Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.

S E Goldblum, W P Reed, L L Barton
PMCID: PMC350643  PMID: 7263061

Abstract

Granulocytopenia seen during human pneumococcal disease is associated with a worsened prognosis. Streptococcus pneumoniae type 1 reduces circulating granulocytes and induces pulmonary leukostasis in rabbits. We studied which type 1 pneumococcal fraction(s) might be responsible for the reduction in circulating granulocytes. Rabbits were challenged intravenously with nonpyrogenic sterile saline, sonicated type 1 pneumococci, capsular polysaccharide from type 1 pneumococci, or cell walls from type 1 pneumococci. Nonviable pneumococci caused a mean decrease in blood granulocytes of 64% as compared with a mean increase of 124% in saline-injected controls, a difference significant at P less than 0.001. Pneumococcal cell walls induced significant decreases in circulating granulocytes at all doses tested when compared with saline-injected controls, whereas capsular polysaccharide induced no reduction in granulocytes. On a weight-for-weight basis, cell wall induced significantly more granulocyte reduction than did capsular polysaccharide at doses of either 10 mg (P less than 0.01) or 20 mg (P less than 0.005). A nonencapsulated pneumococcus also induced a profound granulocyte reduction (mean decrease in blood granulocytes, 88%) in the absence of detectable circulating polysaccharide. The cell wall fraction of S. pneumoniae type 1 was a more effective constituent in promoting the reduction in circulating granulocytes in rabbits.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
  2. Coonrod J. D., Drennan D. P. Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses. Ann Intern Med. 1976 Mar;84(3):254–260. doi: 10.7326/0003-4819-84-3-254. [DOI] [PubMed] [Google Scholar]
  3. Coonrod J. D., Jenkins S. Interaction of pneumococcal antigens with complement in rats. Infect Immun. 1979 Mar;23(3):626–632. doi: 10.1128/iai.23.3.626-632.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coonrod J. D., Rytel M. W. Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens. J Lab Clin Med. 1973 May;81(5):770–777. [PubMed] [Google Scholar]
  5. Craddock P. R., Fehr J., Brigham K. L., Kronenberg R. S., Jacob H. S. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977 Apr 7;296(14):769–774. doi: 10.1056/NEJM197704072961401. [DOI] [PubMed] [Google Scholar]
  6. Craddock P. R., Fehr J., Dalmasso A. P., Brighan K. L., Jacob H. S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977 May;59(5):879–888. doi: 10.1172/JCI108710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Craddock P. R., Hammerschmidt D., White J. G., Dalmosso A. P., Jacob H. S. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977 Jul;60(1):260–264. doi: 10.1172/JCI108763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cronberg S., Nilsson I. M. Pneumococcal sepsis with generalised Shwartzman reaction. Acta Med Scand. 1970 Oct;188(4):293–299. doi: 10.1111/j.0954-6820.1970.tb08040.x. [DOI] [PubMed] [Google Scholar]
  9. Dalldorf F. G., Pate D. H., Langdell R. D. Pulmonary capillary thrombosis in experimental pneumococcal septicemia. Arch Pathol. 1968 Feb;85(2):149–161. [PubMed] [Google Scholar]
  10. Dee T. H., Schiffman G., Sottile M. I., Rytel M. W. Immunologic studies in pneumococcal disease. J Lab Clin Med. 1977 Jun;89(6):1198–1207. [PubMed] [Google Scholar]
  11. Dhingra R. K., Williams R. C., Jr, Reed W. P. Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infect Immun. 1977 Jan;15(1):169–174. doi: 10.1128/iai.15.1.169-174.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Edwards M., Stark J. M. The ability of smooth and rough strains of Streptococcus pneumoniae to activate human complement by the alternative pathway. J Med Microbiol. 1978 Feb;11(1):7–14. doi: 10.1099/00222615-11-1-7. [DOI] [PubMed] [Google Scholar]
  13. Fine D. P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. doi: 10.1128/iai.12.4.772-778.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gallin J. I., Durocher J. R., Kaplan A. P. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest. 1975 May;55(5):967–974. doi: 10.1172/JCI108026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldblum S. E., Reed W. P., Sopher R. L., Palmer D. L. Pneumococcus-induced granulocytopenia and pulmonary leukostasis in rabbits. J Lab Clin Med. 1981 Feb;97(2):278–290. [PubMed] [Google Scholar]
  16. Howard L. V., Gooder H. Specificity of the autolysin of Streptococcus (Diplococcus) pneumoniae. J Bacteriol. 1974 Feb;117(2):796–804. doi: 10.1128/jb.117.2.796-804.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marsh J. C., Boggs D. R., Cartwright G. E., Wintrobe M. M. Neutrophil kinetics in acute infection. J Clin Invest. 1967 Dec;46(12):1943–1953. doi: 10.1172/JCI105684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McCall C. E., De Chatelet L. R., Brown D., Lachmann P. New biological activity following intravascular activation of the complement cascade. Nature. 1974 Jun 28;249(460):841–843. doi: 10.1038/249841a0. [DOI] [PubMed] [Google Scholar]
  19. Mosser J. L., Tomasz A. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J Biol Chem. 1970 Jan 25;245(2):287–298. [PubMed] [Google Scholar]
  20. O'Flaherty J. T., Kreutzer D. L., Ward P. A. Neutrophil aggregation and swelling induced by chemotactic agents. J Immunol. 1977 Jul;119(1):232–239. [PubMed] [Google Scholar]
  21. O'Flaherty J. T., Kreutzer D. L., Ward P. A. The influence of chemotactic factors on neutrophil adhesiveness. Inflammation. 1978 Mar;3(1):37–48. doi: 10.1007/BF00917320. [DOI] [PubMed] [Google Scholar]
  22. O'Flaherty J. T., Showell H. J., Ward P. A. Influence of extracellular Ca2+ and Mg2+ on chemotactic factor-induced neutrophil aggregation. Inflammation. 1977 Dec;2(4):265–276. doi: 10.1007/BF00921006. [DOI] [PubMed] [Google Scholar]
  23. O'Flaherty J. T., Showell H. J., Ward P. A. Neutropenia induced by systemic infusion of chemotactic factors. J Immunol. 1977 May;118(5):1586–1589. [PubMed] [Google Scholar]
  24. Perry J. E., Cluff L. E. Clinical and bacteriological events in experimental lethal pneumococcal infection. Tex Rep Biol Med. 1966 Spring;24(1):125–140. [PubMed] [Google Scholar]
  25. Prellner K. Complement activation by pneumococci associated with acute otitis media. Acta Pathol Microbiol Scand C. 1979 Jun;87C(3):213–216. [PubMed] [Google Scholar]
  26. ROGERS D. E. Host mechanisms which act to remove bacteria from the blood stream. Bacteriol Rev. 1960 Mar;24(1):50–66. doi: 10.1128/br.24.1.50-66.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rutstein D. D., Walker W. H. COMPLEMENT ACTIVITY IN PNEUMONIA. J Clin Invest. 1942 May;21(3):347–352. doi: 10.1172/JCI101308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sacks T., Moldow C. F., Craddock P. R., Bowers T. K., Jacob H. S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest. 1978 May;61(5):1161–1167. doi: 10.1172/JCI109031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schenk E. A., Panke T. W., Cole H. A. Glomerular and arteriolar thrombosis in pneumococcal septicemia. Arch Pathol. 1970 Feb;89(2):154–159. [PubMed] [Google Scholar]
  31. Stephens C. G., Williams R. C., Jr, Reed W. P. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stossel T. P., Levy R. Intravascular coagulation associated with pneumococcal bacteremia and symmetrical peripheral gangrene. Arch Intern Med. 1970 May;125(5):876–878. [PubMed] [Google Scholar]
  33. Winkelstein J. A., Bocchini J. A., Jr, Schiffman G. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol. 1976 Feb;116(2):367–370. [PubMed] [Google Scholar]
  34. Winkelstein J. A., Shin H. S., Wood W. B., Jr Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol. 1972 Jun;108(6):1681–1689. [PubMed] [Google Scholar]
  35. Winkelstein J. A., Tomasz A. Activation of the alternative pathway by pneumococcal cell walls. J Immunol. 1977 Feb;118(2):451–454. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES